Stevenage Bioscience Catalyst (SBC) has launched a free accelerator programme to give data-focused biotech start-ups the skills they need to get potential new drugs and therapies to market more quickly.
Stevenage Bioscience Catalyst
Stevenage Bioscience Catalyst is a leading location for development and commercialisation of advanced therapeutics. The Campus is home to GSK, the Cell & Gene Therapy Manufacturing Catapult, LifeArc and Cytiva plus 40+ start-up companies which together have raised £1.8 bn equity investment, IPO/FPO, grants and acquisitions since 2012. The facilities provide business support, scientific equipment and scale up advice.